Alison J. Ford

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Health funders' dissemination and implementation practices: results from a survey of the Ensuring Value in Research (EViR) Funders' Forum.

Health funders' dissemination and implementation practices: results from a survey of the Ensuring Value in Research (EViR) Funders' Forum.

Journal: Implementation science communications

Published: May 21, 2021

Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis.

Identification of selective 8-(piperidin-4-yloxy)quinoline sulfone and sulfonamide histamine H1 receptor antagonists for use in allergic rhinitis.

Journal: Bioorganic & medicinal chemistry letters

Published: August 22, 2017

Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis.

Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis.

Journal: ACS medicinal chemistry letters

Published: April 05, 2017

Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.

Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.

Journal: Bioorganic & medicinal chemistry

Published: February 13, 2014

Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.

Discovery of a rapidly metabolized, long-acting β(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.

Journal: Journal of medicinal chemistry

Published: December 24, 2013

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.

Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.

Journal: European journal of pharmacology

Published: October 22, 2013

Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.

Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.

Journal: Journal of medicinal chemistry

Published: February 16, 2013

In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.

In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.

Journal: The Journal of pharmacology and experimental therapeutics

Published: November 08, 2012

Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.

Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.

Journal: Bioorganic & medicinal chemistry letters

Published: January 13, 2012

Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

Journal: British journal of pharmacology

Published: October 26, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026